98 related articles for article (PubMed ID: 12061263)
1. Enalapril maleate polymorphs: instability of form II in a tablet formulation.
Eyjolfsson R
Pharmazie; 2002 May; 57(5):347-8. PubMed ID: 12061263
[No Abstract] [Full Text] [Related]
2. Use of microcalorimetry in determination of stability of enalapril maleate and enalapril maleate tablet formulations.
Simoncic Z; Zupancic P; Roskar R; Gartner A; Kogej K; Kmetec V
Int J Pharm; 2007 Sep; 342(1-2):145-51. PubMed ID: 17597314
[TBL] [Abstract][Full Text] [Related]
3. Enalapril maleate form II: stabilization in a tablet formulation.
Eyjolfsson R
Pharmazie; 2003 May; 58(5):357. PubMed ID: 12779058
[No Abstract] [Full Text] [Related]
4. Design and evaluation of a new formulation of enalapril maleate tablet.
Bibi R; Naqvi BS; Shoaib MH; Rahim N
Pak J Pharm Sci; 2011 Apr; 24(2):211-5. PubMed ID: 21454172
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of degradation of enalapril maleate in dosage forms.
Stanisz B
Acta Pol Pharm; 2004; 61(6):415-8. PubMed ID: 15794332
[TBL] [Abstract][Full Text] [Related]
6. Stability of extemporaneous enalapril maleate suspensions for pediatric use prepared from commercially available tablets.
Sosnowska K; Winnicka K; Czajkowska-Kośnik A
Acta Pol Pharm; 2009; 66(3):321-6. PubMed ID: 19645333
[TBL] [Abstract][Full Text] [Related]
7. Stability and in vitro release profile of enalapril maleate from different commercially available tablets: possible therapeutic implications.
Lima DM; dos Santos LD; Lima EM
J Pharm Biomed Anal; 2008 Aug; 47(4-5):934-7. PubMed ID: 18472382
[TBL] [Abstract][Full Text] [Related]
8. Proposal of a new degradation mechanism of enalapril maleate and improvement of enalapril maleate stability in tablet formulation with different stabilizers.
Chen J; Zhang LH; Xu RJ; Bu NJ; Zhang L
Pharmazie; 2014 Apr; 69(4):277-80. PubMed ID: 24791591
[TBL] [Abstract][Full Text] [Related]
9. The application of VIS spectrophotometric determination of enalapril maleate in substance, in tablets and estimation of ester group stability.
Stanisz B
Acta Pol Pharm; 1999; 56(6):431-4. PubMed ID: 10715888
[TBL] [Abstract][Full Text] [Related]
10. Effect of the drug-matrix on the stability of enalapril maleate in tablet formulations.
Al-Omari MM; Abdelah MK; Badwan AA; Jaber AM
J Pharm Biomed Anal; 2001 Jul; 25(5-6):893-902. PubMed ID: 11377072
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of stability of enalapril maleate in solid phase.
Stanisz B
J Pharm Biomed Anal; 2003 Feb; 31(2):375-80. PubMed ID: 12609677
[TBL] [Abstract][Full Text] [Related]
12. Role of continuous moisture profile monitoring by inline NIR spectroscopy during fluid bed granulation of an Enalapril formulation.
Hartung A; Knoell M; Schmidt U; Langguth P
Drug Dev Ind Pharm; 2011 Mar; 37(3):274-80. PubMed ID: 20815795
[TBL] [Abstract][Full Text] [Related]
13. Influence of different types of commercially available microcrystalline cellulose on degradation of perindopril erbumine and enalapril maleate in binary mixtures.
Vehovec T; Gartner A; Planinšek O; Obreza A
Acta Pharm; 2012 Dec; 62(4):515-28. PubMed ID: 23333887
[TBL] [Abstract][Full Text] [Related]
14. Stability of enalapril maleate in three extemporaneously prepared oral liquids.
Nahata MC; Morosco RS; Hipple TF
Am J Health Syst Pharm; 1998 Jun; 55(11):1155-7. PubMed ID: 9626379
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous quantification of enalapril and enalaprilat in human plasma by high-performance liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study.
Lu S; Jiang K; Qin F; Lu X; Li F
J Pharm Biomed Anal; 2009 Jan; 49(1):163-7. PubMed ID: 19046843
[TBL] [Abstract][Full Text] [Related]
16. Study of the effect of formulation variables on the characteristics of combination tablets containing enalapril maleate and indapamide as active substances using experimental design.
Szabó ZI; Székely-Szentmiklósi B; Deák B; Székely-Szentmiklósi I; Kovács B; Zöldi K; Sipos E
Acta Pharm; 2016 Jun; 66(2):191-206. PubMed ID: 27279063
[TBL] [Abstract][Full Text] [Related]
17. Physicochemical stability of captopril and enalapril extemporaneous formulations for pediatric patients.
Casas M; Álvarez J; Lucero MJ
Pharm Dev Technol; 2015 May; 20(3):271-8. PubMed ID: 24279906
[TBL] [Abstract][Full Text] [Related]
18. Counter-current chromatographic estimation of hydrophobicity of Z-(cis) and E-(trans) enalapril and kinetics of cis/trans isomerization.
Shoji A; Yanagida A; Shindo H; Ito Y; Shibusawa Y
J Chromatogr A; 2007 Jul; 1157(1-2):101-7. PubMed ID: 17467722
[TBL] [Abstract][Full Text] [Related]
19. Stability of new potential ACE inhibitor in the aqueous solutions of different pH.
Roskar R; Simoncic Z; Gartner A; Kmetec V
J Pharm Biomed Anal; 2009 Feb; 49(2):295-303. PubMed ID: 19135817
[TBL] [Abstract][Full Text] [Related]
20. Structure determination of enalapril maleate form II from high-resolution X-ray powder diffraction data.
Kiang YH; Huq A; Stephens PW; Xu W
J Pharm Sci; 2003 Sep; 92(9):1844-53. PubMed ID: 12950002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
